Biotech for less than cash value Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JMarcus who wrote (247)	12/8/2005 11:06:46 PM
From: Jibacoa	of 684

PARS Has been forming a good base at the $1.95 to $2 level. If it can get to close half of its December 20 downgap, it would be a good % gain from present level. (To close half of the gap, it would have to get to the $11 level.<G>) As Dutton Associates mentioned PARS has around $50M in cash and a burn rate of approximately $12.5M over the next few years.They expect an 80% appreciation in price, but I don't know if they are taking into account all the "class action lawsuits".<g> Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next